Literature DB >> 24343057

[Venous and arteriovenous malformations in the head and neck region. Therapeutic options and challenges].

B Eivazi1, J A Werner.   

Abstract

Venous malformations are the prototype low-flow malformations in the head and neck region. Arteriovenous malformations (AVM) represent the main high-flow malformations. In recent years it has been possible to significantly optimize the therapeutic options for venous malformations. In addition to conventional surgery, laser treatment and sclerotherapy have become established techniques and the importance of embolization with new alcohol-based materials is increasing. AVM are progressive and destructive diseases. Therapy of choice is usually a combined treatment comprising embolization and surgical removal of the arteriovenous nidus. This curative approach is usually possible if diagnosis is made at an early stage. Incomplete embolization or sole ligation of the arterial supply causes progression. There is a clear need for improved therapeutic methods and pharmacotherapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24343057     DOI: 10.1007/s00106-013-2805-1

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  23 in total

1.  Phleboliths from venous malformations of the head and neck.

Authors:  B Eivazi; A J Fasunla; C Güldner; P Masberg; J A Werner; A Teymoortash
Journal:  Phlebology       Date:  2013-05-06       Impact factor: 1.740

2.  Safety and clinical efficacy of Onyx for embolization of extracranial head and neck vascular anomalies.

Authors:  R Thiex; I Wu; J B Mulliken; A K Greene; R Rahbar; D B Orbach
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-31       Impact factor: 3.825

3.  Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.

Authors:  M Vikkula; L M Boon; K L Carraway; J T Calvert; A J Diamonti; B Goumnerov; K A Pasyk; D A Marchuk; M L Warman; L C Cantley; J B Mulliken; B R Olsen
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

4.  Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies.

Authors:  Jennifer J Marler; Steven J Fishman; Susan M Kilroy; Jianmin Fang; Joseph Upton; John B Mulliken; Patricia E Burrows; David Zurakowski; Judah Folkman; Marsha A Moses
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

5.  Treatment of venous malformations: first experience with a new sclerosing agent--a multicenter study.

Authors:  Martin Schumacher; Patrick Dupuy; Jean-Michel Bartoli; Ulrike Ernemann; Denis Herbreteau; Corinne Ghienne; Laurent Guibaud; Dirk A Loose; Raul Mattassi; Philippe Petit; Jochen K Rössler; Francesco Stillo; Johannes Weber
Journal:  Eur J Radiol       Date:  2011-04-01       Impact factor: 3.528

Review 6.  Current management of hemangiomas and vascular malformations.

Authors:  Jennifer J Marler; John B Mulliken
Journal:  Clin Plast Surg       Date:  2005-01       Impact factor: 2.017

7.  Arteriovenous malformations of the head and neck: natural history and management.

Authors:  M P Kohout; M Hansen; J J Pribaz; J B Mulliken
Journal:  Plast Reconstr Surg       Date:  1998-09       Impact factor: 4.730

Review 8.  Update on hemangiomas and vascular malformations of the head and neck.

Authors:  Behfar Eivazi; Mircia Ardelean; Wolfgang Bäumler; Hans-Peter Berlien; Hansjörg Cremer; Ravindhra Elluru; Peter Koltai; Jan Olofsson; Gresham Richter; Bernhard Schick; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-04       Impact factor: 2.503

Review 9.  Treatment guideline for hemangiomas and vascular malformations of the head and neck.

Authors:  Jia Wei Zheng; Qin Zhou; Xiu Juan Yang; Yan An Wang; Xin Dong Fan; Guo Yu Zhou; Zhi Yuan Zhang; James Y Suen
Journal:  Head Neck       Date:  2010-08       Impact factor: 3.147

10.  Surgery in patients with vascular malformations of the head and neck: value of coagulation disorders.

Authors:  S Wiegand; B Eivazi; R Karger; B Al Kadah; A M Sesterhenn; J A Werner
Journal:  Phlebology       Date:  2009-02       Impact factor: 1.740

View more
  4 in total

Review 1.  [Interventional radiology in the head and neck region].

Authors:  C Mayer; E Hattingen; H Schild; F Bootz; A Schröck
Journal:  HNO       Date:  2017-06       Impact factor: 1.284

2.  Curative effects of RF combined with DSA-guided ethanol sclerotherapy in venous malformations.

Authors:  Xing Wang; Jian Meng; Jie Zhang; Ruihan Wu; Jianmin Gu; Cuiling Shao; Kun Han
Journal:  Exp Ther Med       Date:  2016-10-13       Impact factor: 2.447

3.  Pingyangmycin Pretreatment Influences the Biological Behavior of Ocular Venous Malformation and Relates with Galectin-3 Expression.

Authors:  Jin Li; Jun-Bo Qiao; Qiu-Yu Liu
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

4.  Clinical significance of galectin-3 expression in malformed hepatic venous tissue.

Authors:  Junbo Qiao; Yongwei Chen; Changxian Dong; Jin Li
Journal:  Indian J Med Res       Date:  2018-12       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.